Acute renal colic pain. Unspecified renal colic
Conditions
Interventions
Intervention 1: Intervention group: Ketorolac with a dose of 30 mg and gabapentin from Mehr Daroo Pharmaceutical Company, two capsules with a dose of 300 mg and morphine with a dose of 0.05 mg per kg
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-85 years with moderate to severe acute renal colic pain Obtaining informed written consent from the patient
Exclusion criteria
Exclusion criteria: History of severe kidney failure History of moderate to severe liver failure History of allergic reactions to gabapentin or its formulation components Consumption of pregabalin and gabapentin during the last week Intolerance to food Dissatisfaction with entering the study History of unknown lung disease or history of pulmonary insufficiency in COPD or fibrosis of the lung
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The average pain intensity at 4 o'clock. Timepoint: Measurement of pain intensity at the time of patient admission and then every 5 minutes after drug administration and finally 4 and 8 hours after drug administration. Method of measurement: Ask the patient how much pain using the Visual Analogue Scale method. | — |
Secondary
| Measure | Time frame |
|---|---|
| The average amount of morphine consumed in each group. Timepoint: At the time of the patient's arrival and every 5 minutes after the drug is administered, morphine is added to the treatment as rescue if the pain is severe (pain above 7 out of 10). Method of measurement: Sum of the amount of morphine consumed from the moment of arrival until the patient is discharged.;Mean pain control time. Timepoint: From the moment the patient arrives until discharge. Method of measurement: From ketorolac injection to pain control below 5, no narcotics (at least 3 hours after the last narcotics) or discharge. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhad Najmeddin
Tehran University of Medical Sciences
Outcome results
None listed